Yellow Fever Vaccine Market Size, Share, By Product Type (Powder and Liquid), By End-user (Hospitals, Diagnostic Centers, Point of care Centers, and Others), and By Region - Trends, Analysis and Forecast till 2030

Yellow Fever Vaccine market accounted for USD 4.1 Billion in 2020 and is estimated to be USD 5.92 Billion by 2030 and is anticipated to register a CAGR of 3.8%.

Yellow fever is a viral infection. It is transmitted from infected female mosquitoes, a particular type of mosquito species known as Aedes. Yellow fever infection is also spread by haemogogus mosquito’s species. The yellow fever infection occurs globally but the occurrence of fever is majorly found in 47 endemic countries of Latin America, Central America and African region. Humans and monkeys are most frequently infected with the yellow fever due to viral infection. Children’s & elderly people are more prone to the yellow fever infection because of poor immune response. The signs of the mild yellow fever are fever, headache, vomiting and nausea but the in some cases, the symptoms can be more severe and resulted into heart, kidney and liver problems along with the internal bleeding.

Growing prevalence of the yellow fever disease

Growing prevalence of the yellow fever disease as viral infection is easily spreading by the mosquitoes, which is projected to drive the demand for yellow fever treatment and enhances the growth of the global yellow fever vaccine market throughout the forecast period. The yellow fever vaccine is affordable, safe and it also provide life-long immunity against yellow fever viral infection, which also expected to propel the growth of the global yellow fever vaccine market. Continuous research and development activities in the yellow fever and related disease treatment are also driving growth of the global market. Further, stringent regulations and strongly recommends by the WHO regarding vaccination for every person who is older than 9 months in the disease prone area. WHO also recommends vaccination for all travelers who visit areas prone to the risk of yellow fever, is anticipated to propel the demand for the target market over the forecast period.

However, the possible side effects of yellow fever vaccination such as muscle pain, headache, swelling, joint pain, and body aches may hinder the demand for the global market

Yellow fever vaccine market is segmented based on product type, end-user, and region.

On the basis of product type, the global yellow fever vaccine market is segmented into powder and liquid. Based on end-user, the target market is classified into hospitals, diagnostic centers, point of care centers, and others

Regional Insights:

The Yellow Fever Vaccine market accounted for US$ 4.1 billion in 2020 and is estimated to be US$ 5.92 billion by 2030 and is anticipated to register a CAGR of 3.8%. On region the global yellow fever vaccine market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Middle East & Africa accounts for the highest share in global yellow fever vaccine Market due to highest incidence of yellow fever in this region. Latin America is expected to account the second largest revenue share due to rising medical tourisms in Brazil and Mexico. Further, suitable expenditure on medical and emergency care by international healthcare and public groups, especially from United Nations and Western Europe also drives growth in this region. Penetration of advanced therapeutic line of treatment in rural and semi urban counties in Latin America. Adoption of commercialized vaccines in the end user segment manufactured by overseas manufacturers is going to boost revenue growth over the forecast period in Latin America

Yellow Fever Vaccine Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global Yellow fever vaccine market report based on product, end-user, and region.

Yellow Fever Vaccine Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the global yellow fever vaccine market includes Sanofi Pasteur SA, Bio-Manguinhos, FSUE Chumakov, Institute Pasteur de Dakar, and iBio Inc. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. For instance, in Feb 2020, iBio, a worldwide leader in plant-based biologics manufacturing in Bryan, has partnered with Beijing CC-Pharming Ltd to produce and test a new 2019-nCoV vaccine to fight the coronavirus outbreak. 

• Sanofi Pasteur SA
• Bio-Manguinhos
• Institut Pasteur de Dakar
• FSUE Chumakov
• iBio Inc.